Regulatory versus Public Health Requirements in Clinical Trials

This publication has 13 references indexed in Scilit:

• Explanatory and pragmatic attitudes in therapeutical trials
  Published by Elsevier ,2004
• Statistical Issues Arising in AIDS Clinical Trials
  Journal of the American Statistical Association, 1992
• ISIS-3: a randomised comparison of streptokinase vs tissue plasminogen activator vs anistreplase and of aspirin plus heparin vs aspirin alone among 41 299 cases of suspected acute myocardial infarction
  Published by Elsevier ,1992
• AXIS – A suitable case for treatment
  British Journal of Cancer, 1991
• Chemotherapy in advanced ovarian cancer: an overview of randomised clinical trials. Advanced Ovarian Cancer Trialists Group.
  BMJ, 1991
• Cyclophosphamide plus cisplatin versus cyclophosphamide, doxorubicin, and cisplatin chemotherapy of ovarian carcinoma: a meta-analysis. The Ovarian Cancer Meta-Analysis Project.
  Journal of Clinical Oncology, 1991
• Effects of Adjuvant Tamoxifen and of Cytotoxic Therapy on Mortality in Early Breast Cancer
  New England Journal of Medicine, 1988
• Adjuvant Therapy of Colorectal Cancer
  Published by American Medical Association (AMA) ,1988
• Why do we need some large, simple randomized trials?
  Statistics in Medicine, 1984
• Critical Issues in the Conduct and Interpretation of Clinical Trials
  Annual Review of Public Health, 1983